Atlas Trials

Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's Lymphoma

Clinical trial NCT00383097 · TERMINATED

Trial details

NCT number
NCT00383097
Sponsor
Baylor College of Medicine
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Hodgkins LymphomaNon-Hodgkin Lymphoma
Start date
2006-09-01
Primary completion
2010-02-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.